1. Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry. (August 2022) Authors: Singer, C.F.; Jahn, S.W.; Rudas, M.; Bago-Horvath, Z.; Fitzal, F.; Abete, L.; Moinfar, F.; Gnant, M.; Filipits, M.; Gnant, M. Journal: Breast Issue: Volume 64(2022) Page Start: 127 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P270 Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?. (April 2023) Authors: Wimmer, K.; Hlauschek, D.; Balic, M.; Pfeiler, G.; Strobl-Kacerovsky, S.; Greil, R.; Singer, C.F.; Halper, S.; Steger, G.; Suppan, C.; Gampenrieder, S.P.; Helfgott, R.; Egle, D.; Filipits, M.; Jakesz, R.; Sölkner, L.; Fesl, C.; Gnant, M.; Fitzal, F. Journal: Breast Issue: Volume 68(2023)Supplement Page Start: S123 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Prognostic role of pretreatment plasma fibrinogen in patients with solid tumors: A systematic review and meta-analysis. Issue 10 (December 2015) Authors: Perisanidis, C.; Psyrri, A.; Cohen, E.E.; Engelmann, J.; Heinze, G.; Perisanidis, B.; Stift, A.; Filipits, M.; Kornek, G.; Nkenke, E. Journal: Cancer treatment reviews Issue: Volume 41:Issue 10(2015) Page Start: 960 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer. (August 2019) Authors: Singer, C.F.; Filipits, M.; Jahn, S.W.; Abete, L.; Jakesz, R.; Greil, R.; Bauernhofer, T.; Kwasny, W.; Seifert, M.; Fitzal, F.; Kastner, M.; Schmitt, M.; Moinfar, F.; Gnant, M. Journal: Breast Issue: Volume 46(2019) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗